Clinical Investigations Under MDR

    Clinical

    Clinical Investigations Under MDR

    The EU MDR has brought greater consistency to clinical investigations, but navigating the process across Member States is still far from straightforward.

    From regulatory pathways and ethics approvals to tight timelines and post-market requirements, successful execution starts with knowing what to expect.

    Discover the key MDR requirements and practical lessons for planning and conducting medical device clinical investigations in Europe.

    About This White Paper

    The Medical Device Regulation has significantly raised the bar for clinical evidence, regulatory oversight and post-market surveillance in Europe. Manufacturers must carefully assess whether their existing clinical data is sufficient, and where gaps remain, additional pre-market or post-market clinical investigations may be needed.

    This white paper combines MDR requirements with practical experience from medical device clinical investigations across Europe. It explains how to determine the appropriate regulatory pathway, navigate submissions to competent authorities and ethics committees, and account for country-specific differences that still exist despite the MDR's harmonization goals.

    You'll also gain insight into MDR timelines, the role of the EU Legal Representative, reporting requirements during study conduct and the growing importance of Post-Market Clinical Follow-up (PMCF), along with a look at how EUDAMED and coordinated assessments could further simplify European clinical investigations in the future.

    Key Takeaways

    ✓ Determine the Right MDR Regulatory Pathway. Understand how factors such as CE-marking status, intended purpose and the role of the investigation in conformity assessment determine whether Article 62, Article 74 or other provisions apply.

    ✓ Navigate Country-Specific Submission Requirements. Learn why differences between Member States remain, particularly around regulatory assessment and ethics committee review, and why country and site selection can directly affect your submission strategy and timelines.

    ✓ Prepare for Strict MDR Timelines. Understand the authorization process, Requests for Information and sponsor response windows, and why a complete, accurate submission package is critical to avoiding unnecessary delays.

    ✓ Understand the Role of the EU Legal Representative. Discover what sponsors outside the EU need to know about appointing a Legal Representative, including their increased responsibilities and role as a key point of contact under MDR.

    ✓ Manage MDR Requirements Throughout Study Conduct. Get familiar with reporting obligations for study start and end, safety events and other key milestones, and understand where MDR has created greater consistency across European countries.

    ✓ Plan for Post-Market Clinical Evidence. Explore the growing role of PMCF and the different approaches manufacturers can use to continuously gather evidence on device safety and performance after market launch.

    Download now

    First name*

    Last name*

    Professional Email*

    Company name*

    Role*

    Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther

    Department*

    Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther

    Industry *

    Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther

    Country*

    Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

    Content Title

    Content Type

    Content Division

    Content Industry

    QbD Group is committed to protecting and respecting your privacy, and we'll use your personal information to administer your account and to provide the products and services you requested from us.

    • Yes, I agree to receive personalized newsletters with market insights, invitations for exclusive events and educational webinars from the QbD Group.

    • I consent to the privacy policy and understand that my personal data will be stored and processed

    Circles_quotemobile-shape